Revolution Medicines Officer Files Form 144 to Sell $3.21M in Common Stock
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 144 Notice of Proposed Sale Company: Revolution Medicines, Inc. ($RVMD) Insider: Anthony Mancini (Officer) Filing Date: 2026-09-10
Transaction Details: ā¢ Proposed Shares to Sell: 15,448 ā¢ Aggregate Market Value: $3,208,240.64 (~$207.68/share) ā¢ Plan Adoption Date: 2026-06-11 (Rule 10b5-1) ā¢ Broker: Morgan Stanley Smith Barney LLC
Comprehensive Analysis
Executive Summary
On September 10, 2026, Anthony Mancini, an Officer of Revolution Medicines, Inc. ($RVMD), filed a Form 144 notice proposing the sale of 15,448 shares of Common Stock with an estimated aggregate market value of $3,208,240.64 (~$207.68 per share).
Transaction & Plan Details
- Securities to be Sold: 15,448 Common shares comprised of:
- 9,363 shares acquired on September 10, 2026, via stock option exercise.
- 6,085 shares acquired on June 15, 2026, via restricted stock units (RSUs).
- Trading Plan: The transaction is scheduled pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2026.
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
- Past 3-Month Activity: Mr. Mancini previously sold 4,615 shares on June 16, 2026, generating gross proceeds of $720,490.11.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.